| Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission GS Cooke, I Andrieux-Meyer, TL Applegate, R Atun, JR Burry, ... The lancet Gastroenterology & hepatology 4 (2), 135-184, 2019 | 540* | 2019 |
| The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans F Benhamed, PD Denechaud, M Lemoine, C Robichon, M Moldes, ... The Journal of clinical investigation 122 (6), 2176-2194, 2012 | 430 | 2012 |
| The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa M Lemoine, Y Shimakawa, S Nayagam, M Khalil, P Suso, J Lloyd, ... Gut 65 (8), 1369-1376, 2016 | 398 | 2016 |
| Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ... The Lancet Respiratory Medicine 9 (3), 295-304, 2021 | 289 | 2021 |
| Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol‐related cirrhosis M Lemoine, S Katsahian, M Ziol, P Nahon, N Ganne‐Carrie, F Kazemi, ... Alimentary pharmacology & therapeutics 28 (9), 1102-1110, 2008 | 262 | 2008 |
| Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfection JB Maurice, A Patel, AJ Scott, K Patel, M Thursz, M Lemoine Aids 31 (11), 1621-1632, 2017 | 236 | 2017 |
| Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder JU Kim, A Majid, R Judge, P Crook, R Nathwani, N Selvapatt, ... The Lancet Gastroenterology & Hepatology 5 (10), 886-887, 2020 | 232 | 2020 |
| Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis L Serfaty, M Lemoine Diabetes & metabolism 34 (6), 634-637, 2008 | 205 | 2008 |
| Serum adipokine levels predictive of liver injury in non‐alcoholic fatty liver disease M Lemoine, V Ratziu, M Kim, M Maachi, D Wendum, F Paye, JP Bastard, ... Liver International 29 (9), 1431-1438, 2009 | 200 | 2009 |
| Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges M Lemoine, S Nayagam, M Thursz Future virology 8 (4), 371-380, 2013 | 198 | 2013 |
| Viral hepatitis and the Global Burden of Disease: a need to regroup. GS Cooke, M Lemoine, M Thursz, C Gore, T Swan, A Kamarulzaman, ... Journal of viral hepatitis 20 (9), 600-601, 2013 | 182 | 2013 |
| Reducing the neglected burden of viral hepatitis in Africa: strategies for a global approach M Lemoine, S Eholié, K Lacombe Journal of hepatology 62 (2), 469-476, 2015 | 170 | 2015 |
| Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study M Lemoine, Y Shimakawa, R Njie, M Taal, G Ndow, I Chemin, S Ghosh, ... The Lancet Global Health 4 (8), e559-e567, 2016 | 169 | 2016 |
| Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia Y Shimakawa, M Lemoine, HF Njai, C Bottomley, G Ndow, RD Goldin, ... Gut 65 (12), 2007-2016, 2016 | 166 | 2016 |
| Progress towards elimination goals for viral hepatitis AL Cox, MH El-Sayed, JH Kao, JV Lazarus, M Lemoine, AS Lok, F Zoulim Nature reviews Gastroenterology & hepatology 17 (9), 533-542, 2020 | 163 | 2020 |
| Altered hepatic expression of SREBP-1 and PPARγ is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients M Lemoine, V Barbu, PM Girard, M Kim, JP Bastard, D Wendum, F Paye, ... Aids 20 (3), 387-395, 2006 | 141 | 2006 |
| Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis S Nayagam, L Conteh, E Sicuri, Y Shimakawa, P Suso, S Tamba, R Njie, ... The Lancet Global Health 4 (8), e568-e578, 2016 | 125 | 2016 |
| Battlefield against hepatitis B infection and HCC in Africa M Lemoine, MR Thursz Journal of hepatology 66 (3), 645-654, 2017 | 112 | 2017 |
| Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study M Lewin, V Vilgrain, V Ozenne, M Lemoine, D Wendum, V Paradis, M Ziol, ... Hepatology 50 (2), 528-537, 2009 | 111 | 2009 |
| From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management M Lemoine, L Serfaty, J Capeau Current opinion in infectious diseases 25 (1), 10-16, 2012 | 106 | 2012 |
